[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367156-105":59,"doc-detail-367156-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","intersection-of-rare-pathogenic-variants-from-tcga-in-the-all-of-us-research-program-v6","Intersection of rare pathogenic variants from TCGA in the All of Us Research Program v6","","Rare cancer predisposition alleles derived from The Cancer Genome Atlas (TCGA) and high cancer prevalence in All of Us (version 6) are used to evaluate how rare variants affect cancer occurrence across six genetic similarity groups. Germline susceptibility replicates most consistently in EUR-like participants and less in other groups. Rare pathogenic mutation carriers in EUR, AFR, and MID show higher cancer likelihood. A phenome-wide association study tests links between pathogenic variants and additional phenotypes, with most signals again enriched in EUR-like participants. As the cohort expands, power projections indicate strong detection of common variants but limited sensitivity for rare mutations.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/intersection-of-rare-pathogenic-variants-from-tcga-in-the-all-of-us-research-program-v6/367156/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/intersection-of-rare-pathogenic-variants-from-tcga-in-the-all-of-us-research-program-v6/367156.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What data sources are combined in this study?","Question",{"text":113,"@type":114},"The study uses rare cancer predisposition alleles derived from The Cancer Genome Atlas (TCGA) and cancer-related phenotypes from the All of Us Research Program (version 6), including participant electronic health records.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which genetic similarity group shows the strongest replication of cancer susceptibility?",{"text":118,"@type":114},"Germline susceptibility to cancer consistently replicates in EUR-like participants, while it is less consistent in other genetic similarity groups.",{"name":120,"@type":111,"acceptedAnswer":121},"How does the study evaluate the broader phenotypic impact of rare pathogenic variants?",{"text":122,"@type":114},"It performs a phenome-wide association study (PheWAS) to assess the effect of pathogenic variants on additional phenotypes beyond cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},367156,1790377453,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","ARTICLE  \nIntersection of rare pathogenic variants  \nfrom TCGA in the All of Us Research Program v6  \nBlaine A. Bates, 1,2 Kylee E. Bates,3 Spencer A. Boris,1 Colin Wessman, 1 David Stone,1 Justin Bryan, 1 Mary F. Davis,3,4 and Matthew H. Bailey1,5,6,*  \nSummary  \nUsing rare cancer predisposition alleles derived from The Cancer Genome Atlas (TCGA) and high cancer prevalence (14% of participants) in All of Us (version 6), we assessed the impact of these rare alleles on cancer occurrence in six broad groups of genetic similarity provided by All of Us: African/African American (AFR), Admixed American/Latino (AMR), East Asian (EAS), European (EUR), Middle Eastern (MID), or South Asian (SAS) . We observed that germline susceptibility to cancer consistently replicates in EUR-like participants but less so in other participants. We found that All of Us participants from the EUR (p ¼ 1.8 3 10􀀂7), AFR (p ¼ 0.018), and MID (p ¼ 0.0083) genetic similarity groups who carry a rare pathogenic mutation are more likely to have cancer than those without a rare pathogenic mutation. With the advent of combining medical records and genetic mutations, we also performed a phenome-wide association study (PheWAS) to assess the effect of pathogenic variants on additional phenotypes. This analysis again showed several associations between predisposition variants and cancer in EUR-like participants, but fewer in those of the other genetic similarity groups. As All of Us grows to 1 million participants, our projections suggest sufﬁcient power (>99%) to detect cancer-associated variants that are common, but limited power (􀀃28%) to detect rare mutations when using the entire cohort. This study provides preliminary insights into genetic predispositions to cancer across a diverse cohort and demonstrates the value of All of Us as a resource for cancer research.  \nIntroduction  \nMultifarious omics research has improved our molecular understanding of cancer. With the advent of next-generation sequencing, the past two decades have produced vast amounts of genotypic and phenotypic data. In particular, The Cancer Genome Atlas (TCGA) curated whole exome variant calls1 for somatic,2 RNA-expression,3 copy number,4 aneuploidy,5 and clinical proﬁles.6 Additionally, Huang et al. discovered 500þ pathogenic germline variants within the TCGA dataset7 that likely contribute to cancer. Summatively, this study linked functional consequences to rare predisposition variants that could impact germline testing of cancer. One of the primary limitations of the TCGA cohort is the lack of diversity, reporting that a majority of the cancer types studied were disproportionalto races and stages reported in national cancer registries.8 These discrepancies warrant additional cancer datasets accurately reﬂecting the genetic diversity in the United States.  \nTo address this issue, and many others concerning human health, the National Institutes of Health has produced the All of Us Research Program.9 This phenomenal program has over 400,000 participants who have agreed to share their electronic health records (EHR), and, as of the version 6 data release (All of Us data: [allofus.nih.gov](allofus.nih.gov)), almost 100,000 are paired with whole-genome seque-  \nncing. The All of Us Research Program plans to provide genome sequencing to 1 million participants and intends to release updated data for researchers’ use annually. Participant selection is disease agnostic, and recruitment has focused on underrepresented minorities in the United States, with almost 50% of participants reporting nonWhite. A preliminary analysis of the insurance billing codes suggests that All of Us will be a fruitful dataset for studying cancer. In our study population of 67,598 individuals (see material and methods, Figure 1A), we found 9,780 individuals (14%) with malignant neoplasm records. While 14% is low compared with current estimates of lifetime cancer risk, e.g., >50% according to Ahmad et al.,10 the disproporti","cbCaic3V3XLrLNsi","https://ap.wps.com/l/cbCaic3V3XLrLNsi","pdf",2617161,"English","# Summary\n# Introduction\n## Rationale for using TCGA and All of Us\n## Study population and goals\n## Article license and figure overview","[{\"question\":\"What data sources are combined in this study?\",\"answer\":\"The study uses rare cancer predisposition alleles derived from The Cancer Genome Atlas (TCGA) and cancer-related phenotypes from the All of Us Research Program (version 6), including participant electronic health records.\"},{\"question\":\"Which genetic similarity group shows the strongest replication of cancer susceptibility?\",\"answer\":\"Germline susceptibility to cancer consistently replicates in EUR-like participants, while it is less consistent in other genetic similarity groups.\"},{\"question\":\"How does the study evaluate the broader phenotypic impact of rare pathogenic variants?\",\"answer\":\"It performs a phenome-wide association study (PheWAS) to assess the effect of pathogenic variants on additional phenotypes beyond cancer.\"}]","Intersection of rare pathogenic variants from TCGA in the All of Us Research Program v6 | PDF",1790169527,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d79b320ced26c3b74e5f1be88c9bc613.webp",983,1276,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b23c83d0f4c155abe5a14d625515364.webp",982,1275,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4a8f1111822114895ec87e2c7a4e929.webp",981,1273,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/691259f2119bff6673667dc55d33f847.webp",980,1272]